Revenue: The sum of all revenue fields included for a company's operating activities.
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Revenue of $796.20M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$796.20M |
$57.66M |
|
$461.69M |
|
$334.51M |
|
$666.43M |
|
$129.77M |
|
$-58.78M |
|
$70.99M |
|
$70.99M |
|
$69.61M |
|
$69.61M |
|
$69.61M |
|
$69.61M |
|
$129.77M |
|
$181.63M |
|
319.20M |
|
328.10M |
|
$0.18 |
|
$0.18 |
|
| Balance Sheet Financials | |
$1.95B |
|
$456.88M |
|
$1.83B |
|
$3.78B |
|
$883.19M |
|
$2.56B |
|
$2.86B |
|
$3.74B |
|
$33.02M |
|
$-1.15B |
|
$33.02M |
|
319.33M |
|
| Cash Flow Statement Financials | |
$-47.99M |
|
$-144.45M |
|
$20.31M |
|
$312.94M |
|
$139.62M |
|
$-173.32M |
|
$19.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.20 |
|
-- |
|
-- |
|
0.99 |
|
80.86 |
|
42.01% |
|
16.30% |
|
16.30% |
|
-- |
|
8.92% |
|
7.24% |
|
$-107.44M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.68 |
|
0.78 |
|
115.39 |
|
210.80% |
|
-6.06% |
|
1.84% |
|
2.68% |
|
$0.10 |
|
$-0.33 |
|
$-0.15 |
|